small molecule glp-1 agonist In patients with #obesity, incretin-based therapies such as receptor agonists are reported to result in mean weight reductions of approximately 15 to 20% along with additional health benefits, including decreased cardiovascular A Small-Molecule Oral Agonist of
Description
doi: 10.2337/dc12-2469
Reminder: All proceeds from Ground Truths goes to support Scripps Research.
35,36 Although some studies report smaller reductions in muscle mass, many scientists argue that these findings should not be ignored due to the high metabolic rate of skeletal muscle which plays an important role in maintaining significant weight loss
Some studies have suggested that the proliferation and apoptosis of granulosa cells (GCs) are the root causes of follicular development and atresia, with forkhead box protein O1 (FoxO1) playing an important role in promoting PCOS follicular atresia and GCs apoptosis (162, 163)
a higher 2.4 mg dose in comparison with matched placebos over 68 weeks in 1210 participants (2)
